Glaukos Corp balance sheet
At the end of fiscal 2025, Glaukos Corp had total assets of $893m, total liabilities of $237m and shareholders' equity of $656m. It held $90.8m in cash against $0 of debt: net cash of $90.8m.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7 | 2 | 22 | 6 | 25 | 30 | 62 | 97 | 101 | 120 | 93 | 170 | 91 | 162 |
| Receivables | — | 5 | 8 | 14 | 17 | 19 | 38 | 36 | 33 | 36 | 40 | 61 | 109 | 150 |
| Inventory | — | 2 | 4 | 7 | 11 | 13 | 43 | 16 | 23 | 38 | 42 | 58 | 64 | 61 |
| Total current assets | — | 11 | 104 | 120 | 149 | 177 | 263 | 469 | 486 | 444 | 395 | 450 | 475 | 580 |
| Goodwill | — | — | — | — | — | — | 66 | 66 | 66 | 66 | 66 | 66 | 67 | 67 |
| Total assets | — | 26 | 117 | 134 | 166 | 207 | 818 | 1,006 | 1,050 | 1,002 | 940 | 975 | 893 | 980 |
| Accounts payable | — | 3 | 4 | 3 | 6 | 6 | 6 | 4 | 7 | 14 | 13 | 13 | 25 | 24 |
| Total current liabilities | — | 20 | 20 | 17 | 27 | 30 | 58 | 50 | 63 | 72 | 74 | 75 | 101 | 127 |
| Short-term debt | — | 9 | 9 | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | 9 | 1 | — | — | — | — | 189 | 280 | 281 | 283 | — | — | — |
| Total debt | 0 | 19 | 10 | 3 | 0 | 0 | 0 | 189 | 280 | 281 | 283 | 57 | 0 | 0 |
| Total liabilities | — | 30 | 21 | 17 | 28 | 33 | 145 | 338 | 463 | 472 | 479 | 208 | 237 | 262 |
| Shareholders' equity | −149 | −151 | 95 | 117 | 138 | 174 | 673 | 667 | 587 | 530 | 462 | 767 | 656 | 717 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 148 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net debt (negative = net cash) | −7 | 17 | −12 | −3 | −25 | −30 | −62 | 93 | 179 | 162 | 189 | −113 | −91 | −162 |
| Shares outstanding | — | 37m | 32m | 34m | 35m | 36m | 44m | 45m | 47m | 48m | 49m | 56m | 58m | 59m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 61 | 72 | 83 | 99 | 109 | 120 | 139 | 150 |
| Inventory | 58 | 59 | 65 | 64 | 64 | 62 | 59 | 61 |
| Total current assets | 450 | 445 | 436 | 455 | 475 | 486 | 516 | 580 |
| Goodwill | 66 | 66 | 67 | 67 | 67 | 67 | 67 | 67 |
| Total assets | 975 | 966 | 987 | 999 | 893 | 893 | 921 | 980 |
| Accounts payable | 13 | 16 | 14 | 20 | 25 | 19 | 19 | 24 |
| Total current liabilities | 75 | 69 | 79 | 88 | 101 | 89 | 102 | 127 |
| Total liabilities | 208 | 202 | 222 | 230 | 237 | 222 | 238 | 262 |
| Shareholders' equity | 767 | 764 | 765 | 770 | 656 | 671 | 682 | 717 |
| Shares outstanding | 56m | 57m | 57m | 57m | 58m | 58m | 59m | 59m |
Compare with peers
- Transmedics Group, Inc. balance sheet
- Novocure Ltd balance sheet
- Myriad Genetics Inc balance sheet
- Bioventus Inc. balance sheet
- Irhythm Holdings, Inc. balance sheet
Head to head: GKOS vs TMDXGKOS vs NVCRGKOS vs MYGNBVS vs GKOS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies